Question 1

What are the common side effects of ADHD medications and how do I manage them?

Accepted Answer

The most common stimulant side effects are appetite suppression (~50-60%), insomnia (~25-50%), and headache (~15-25%). Most are dose-related, peak in the first 1-2 weeks, and are manageable without discontinuation. Appetite and growth effects require monitoring but rarely require treatment change. Cardiovascular effects (modest HR and BP increases) require baseline and periodic monitoring. Serious adverse events (psychosis, sudden death) are extremely rare. Non-stimulants have distinct side effect profiles: atomoxetine (GI, sedation, rare hepatotoxicity), alpha-2 agonists (sedation, hypotension, rebound), viloxazine (somnolence in children, insomnia in adults).

Question 2

Will stimulants suppress my patient's appetite?

Accepted Answer

The most common stimulant side effects are appetite suppression (~50-60%), insomnia (~25-50%), and headache (~15-25%). Most are dose-related, peak in the first 1-2 weeks, and are manageable without discontinuation. Appetite and growth effects require monitoring but rarely require treatment change. Cardiovascular effects (modest HR and BP increases) require baseline and periodic monitoring. Serious adverse events (psychosis, sudden death) are extremely rare. Non-stimulants have distinct side effect profiles: atomoxetine (GI, sedation, rare hepatotoxicity), alpha-2 agonists (sedation, hypotension, rebound), viloxazine (somnolence in children, insomnia in adults).

Question 3

How do I manage stimulant-related insomnia?

Accepted Answer

The most common stimulant side effects are appetite suppression (~50-60%), insomnia (~25-50%), and headache (~15-25%). Most are dose-related, peak in the first 1-2 weeks, and are manageable without discontinuation. Appetite and growth effects require monitoring but rarely require treatment change. Cardiovascular effects (modest HR and BP increases) require baseline and periodic monitoring. Serious adverse events (psychosis, sudden death) are extremely rare. Non-stimulants have distinct side effect profiles: atomoxetine (GI, sedation, rare hepatotoxicity), alpha-2 agonists (sedation, hypotension, rebound), viloxazine (somnolence in children, insomnia in adults).

Question 4

What about emotional blunting or rebound irritability?

Accepted Answer

The most common stimulant side effects are appetite suppression (~50-60%), insomnia (~25-50%), and headache (~15-25%). Most are dose-related, peak in the first 1-2 weeks, and are manageable without discontinuation. Appetite and growth effects require monitoring but rarely require treatment change. Cardiovascular effects (modest HR and BP increases) require baseline and periodic monitoring. Serious adverse events (psychosis, sudden death) are extremely rare. Non-stimulants have distinct side effect profiles: atomoxetine (GI, sedation, rare hepatotoxicity), alpha-2 agonists (sedation, hypotension, rebound), viloxazine (somnolence in children, insomnia in adults).

Question 5

Are stimulants safe for the heart?

Accepted Answer

The most common stimulant side effects are appetite suppression (~50-60%), insomnia (~25-50%), and headache (~15-25%). Most are dose-related, peak in the first 1-2 weeks, and are manageable without discontinuation. Appetite and growth effects require monitoring but rarely require treatment change. Cardiovascular effects (modest HR and BP increases) require baseline and periodic monitoring. Serious adverse events (psychosis, sudden death) are extremely rare. Non-stimulants have distinct side effect profiles: atomoxetine (GI, sedation, rare hepatotoxicity), alpha-2 agonists (sedation, hypotension, rebound), viloxazine (somnolence in children, insomnia in adults).

Question 6

What are the side effects of non-stimulant ADHD medications?

Accepted Answer

The most common stimulant side effects are appetite suppression (~50-60%), insomnia (~25-50%), and headache (~15-25%). Most are dose-related, peak in the first 1-2 weeks, and are manageable without discontinuation. Appetite and growth effects require monitoring but rarely require treatment change. Cardiovascular effects (modest HR and BP increases) require baseline and periodic monitoring. Serious adverse events (psychosis, sudden death) are extremely rare. Non-stimulants have distinct side effect profiles: atomoxetine (GI, sedation, rare hepatotoxicity), alpha-2 agonists (sedation, hypotension, rebound), viloxazine (somnolence in children, insomnia in adults).

Question 7

When should side effects make me stop or switch medication?

Accepted Answer

The most common stimulant side effects are appetite suppression (~50-60%), insomnia (~25-50%), and headache (~15-25%). Most are dose-related, peak in the first 1-2 weeks, and are manageable without discontinuation. Appetite and growth effects require monitoring but rarely require treatment change. Cardiovascular effects (modest HR and BP increases) require baseline and periodic monitoring. Serious adverse events (psychosis, sudden death) are extremely rare. Non-stimulants have distinct side effect profiles: atomoxetine (GI, sedation, rare hepatotoxicity), alpha-2 agonists (sedation, hypotension, rebound), viloxazine (somnolence in children, insomnia in adults).

PsychHQ

What Are the Common Side Effects of ADHD Medications and How Do I Manage Them?